EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview

Diogo Nunes iD, Rui Moreira iD, Maria de Jesus Perry iD, Francisca Lopes iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70423 ↗

At a glance

Übersichtsarbeit in ChemMedChem, 2026. Written by Diogo Nunes and 3 co-authors. Institution: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal. Major MEDLINE topics: Antitubercular Agents, Mycobacterium tuberculosis, Drug Discovery, Small Molecule Libraries. 140 references. The full text is freely available in PubMed Central. Funded by: Fundação para a Ciência e a Tecnologia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tuberculosis (TB) remains a global epidemic, and Mycobacterium tuberculosis (Mtb), its etiological agent, continues to be the deadliest single infectious agent worldwide. Our inability to eradicate TB is strongly related to Mtb's ability to alternate between an active and latent disease state, and a lack of pharmacological agents that effectively target the heterogeneity of TB, which leads downstream to the emergence of drug resistance. The ongoing quest to discover novel effective chemical agents to improve anti‐TB regimens remains a significant challenge. Multicomponent reactions (MCRs) have been shown to generate highly diverse chemical libraries in a time‐ and cost‐efficient, sustainable manner, and thus have emerged as powerful tools to accelerate drug discovery and development. This review provides an overview of the chemical libraries of anti‐TB agents developed by MCRs, highlighting the contributions of MCRs to advance anti‐TB drug discovery through a medicinal chemistry approach.

Subjects

MeSH terms (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisDrug DiscoverySmall Molecule LibrariesTuberculosisHumansMolecular StructureMicrobial Sensitivity TestsStructure-Activity Relationship

Author keywords

M ycobacterium tuberculosisdrug discoverymulticomponent reactionstuberculosis

Substances

Antitubercular AgentsSmall Molecule Libraries

Authors and institutions

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

ORCID profiles: Diogo Nunes, Rui Moreira, Maria de Jesus Perry, Francisca Lopes

Funding

  • Fundação para a Ciência e a Tecnologia

Cite

APA

Nunes, D., Moreira, R., Perry, M. J., & Lopes, F. (2026). Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview. ChemMedChem. https://doi.org/10.1002/cmdc.70423

Vancouver

Nunes D, Moreira R, Perry MJ, Lopes F. Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview. ChemMedChem. 2026. doi:10.1002/cmdc.70423

BibTeX
@article{Nunes2026,
  author = {Nunes, Diogo and Moreira, Rui and Perry, Maria de Jesus and Lopes, Francisca},
  title = {Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70423}
}
Start for free →